DEA Evaluation of Abuse Potential of Hallucinogenic
Closed Solicitation Posted
- Solicitation number
- 15DDHQ24R00000021
- Agency
-
Drug Enforcement Administration
Department of Justice
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 611310 Colleges, Universities, and Professional Schools
- PSC
- Q301 Reference Laboratory Testing
- Place of performance
- Virginia 22152, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Drug Enforcement Administration (DEA) is seeking a contractor to evaluate the abuse potential of up to 16 hallucinogenic test substances through a dose response study, including two training drugs and reference drugs. The contractor will be required to provide investigational study results and a description of the methodology used to conduct the investigation in the form of a formal study report. The key objectives are to determine whether these hallucinogenic substances should be controlled under the Controlled Substances Act due to public health concerns. The evaluation criteria include technical capability, staffing approach, past performance, and cost factors. The proposal is due on May 13, 2024, with questions due by April 17, 2024.
This is a full and open competition with no set-aside designation. The period of performance is five years with five ordering periods. The estimated cost per ordering period is $8,000, with the drug cost not to exceed $500 per ordering period. The place of performance is West Springfield, VA 22152, USA.
Notice text
4 versions
Update #4 · Latest ·
Amendment No. 0003 to RFP: 15DDHQ24R00000021 issued to extend/change the RFP Due Date.
Update #3 ·
Amendment No. 0002 to RFP: 15DDHQ24R00000021 issued to add the Pricing Spreadsheet (Attachment 1) and the Sample BPA Call Order (Attachment 2).
Update #2 ·
Amendment No. 0001 to RFP: 15DDHQ24R00000021
Update #1 ·
The Drug and Chemical Evaluation Section (DOE) of the Drug Enforcement Administration’s (DEA) Diversion Control Division (DC) is responsible for evaluating drugs and chemicals to determine whether these substances have abuse potential. Law enforcement and forensic laboratory data have reported increased encounters of hallucinogenic substances. Abuse of some of these hallucinogenic substances has been associated with adverse health events. Due to the public health threat associated with the abuse of hallucinogenic substances, these substances may need to be controlled under the CSA. Pharmacological data is required for this evaluation.
DEA will require investigational study results and a description of the methodology used to conduct the investigation in the form of a formal study report as per the timelines specified in this Statement of Work, if not earlier. The contractor will evaluate a dose response study of two training drugs, reference drugs, and up to 16 hallucinogenic test substances.
Files
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity